Literature DB >> 23887843

Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke.

Inger de Ridder1, Maaike Dirks, Louis Niessen, Diederik Dippel.   

Abstract

BACKGROUND AND
PURPOSE: A recent meta-analysis showed that women with acute ischemic stroke are less likely to receive treatment with intravenous alteplase than men. The aim of this study was to assess sex differences in treatment with intravenous alteplase and to explore the reasons for these differences.
METHODS: We analyzed data from the Promoting Acute Thrombolysis for Ischaemic Stroke (PRACTISE) study. We applied a multiple logistic regression model and expressed the association between sex and treatment with an age-adjusted odds ratio with 95% confidence interval.
RESULTS: In total, 5515 patients were included in PRACTISE. Women were an average of 4 years older than men. The median National Institutes of Health Stroke Scale score was 6 in women and 5 in men. Fewer women were treated with intravenous alteplase (11% versus 14%; adjusted odds ratio, 0.8; 95% confidence interval, 0.7-1.0). However, fewer women arrived within 4 hours after onset (27% versus 33%; adjusted odds ratio, 0.8; 95% confidence interval, 0.7-0.9).
CONCLUSIONS: Fewer women present themselves within 4 hours from stroke onset than men and consequently less often receive thrombolytic treatment. This difference may be caused by the older age of women on average and consequently women more often living alone. CLINICAL TRIAL REGISTRATION URL: http://www.controlled-trials.com. Unique identifier: ISRCTN20405426.

Entities:  

Keywords:  stroke; thrombolytic therapy; time to treatment

Mesh:

Substances:

Year:  2013        PMID: 23887843     DOI: 10.1161/STROKEAHA.113.002263

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Under-representation of women in stroke randomized controlled trials: inadvertent selection bias leading to suboptimal conclusions.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Valeria Caso
Journal:  Ther Adv Neurol Disord       Date:  2017-03-16       Impact factor: 6.570

2.  Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky Stroke Study.

Authors:  Tracy E Madsen; Jane C Khoury; Kathleen A Alwell; Charles J Moomaw; Brett M Kissela; Felipe De Los Rios La Rosa; Daniel Woo; Opeolu Adeoye; Matthew L Flaherty; Pooja Khatri; Simona Ferioli; Dawn Kleindorfer
Journal:  Stroke       Date:  2015-01-27       Impact factor: 7.914

Review 3.  Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.

Authors:  Ronée E Harvey; Kirsten E Coffman; Virginia M Miller
Journal:  Womens Health (Lond)       Date:  2015-03

Review 4.  Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease.

Authors:  Karina Gasbarrino; Diana Di Iorio; Stella S Daskalopoulou
Journal:  Eur Heart J       Date:  2022-02-10       Impact factor: 29.983

5.  Gender and Time to Arrival among Ischemic Stroke Patients in the Greater Cincinnati/Northern Kentucky Stroke Study.

Authors:  Tracy E Madsen; Heidi Sucharew; Brian Katz; Kathleen A Alwell; Charles J Moomaw; Brett M Kissela; Matthew L Flaherty; Daniel Woo; Pooja Khatri; Simona Ferioli; Jason Mackey; Sharyl Martini; Felipe De Los Rios La Rosa; Dawn Kleindorfer
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-11-23       Impact factor: 2.136

6.  rLOAD: does sex mediate the effect of acute antiplatelet loading on stroke outcome.

Authors:  Dawn M Meyer; Jo-Ann Eastwood; M Peggy Compton; Karen Gylys; Justin A Zivin
Journal:  Biol Sex Differ       Date:  2014-07-15       Impact factor: 5.027

7.  A novel design process for selection of attributes for inclusion in discrete choice experiments: case study exploring variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke.

Authors:  Aoife De Brún; Darren Flynn; Laura Ternent; Christopher I Price; Helen Rodgers; Gary A Ford; Matthew Rudd; Emily Lancsar; Stephen Simpson; John Teah; Richard G Thomson
Journal:  BMC Health Serv Res       Date:  2018-06-22       Impact factor: 2.655

8.  Does Sex Modify the Effect of Endovascular Treatment for Ischemic Stroke?

Authors:  Vicky Chalos; Inger R de Ridder; Hester F Lingsma; Scott Brown; Robert J van Oostenbrugge; Mayank Goyal; Bruce C V Campbell; Keith W Muir; Francis Guillemin; Serge Bracard; Philip White; Antoni Dávalos; Tudor G Jovin; Michael D Hill; Peter J Mitchell; Andrew M Demchuk; Jeffrey L Saver; Wim H van Zwam; Diederik W J Dippel
Journal:  Stroke       Date:  2019-08-15       Impact factor: 7.914

9.  Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature.

Authors:  Angelos Sharobeam; Brett Jones; Dianne Walton-Sonda; Christian J Lueck
Journal:  J Neurol       Date:  2020-03-21       Impact factor: 4.849

10.  Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke.

Authors:  David Nathanson; Cesare Patrone; Thomas Nyström; Mia von Euler
Journal:  Stroke Res Treat       Date:  2014-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.